← Open Payments lookup

BERHANE MEBRATU: Open Payments

NPI 1043718927 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,975 in 107 payments from 44 companies in 2025. Trend: 2023 $1,997 · 2024 $2,980 · 2025 $2,975

Food & beverage: $2,796Education: $178
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation11$274
Astellas Pharma US Inc3$201
Merck Sharp & Dohme LLC8$201
PFIZER INC.8$169
AstraZeneca Pharmaceuticals LP6$160
ABBVIE INC.6$143
Janssen Biotech, Inc.5$140
Genentech USA, Inc.4$121
E.R. Squibb & Sons, L.L.C.4$112
Celgene Corporation3$109

Products named: KEYTRUDA, VENCLEXTA, SCEMBLIX, REBLOZYL, LYNPARZA, OJJAARA, Enhertu, TAVALISSE.

Industry payments across OR — which companies pay providers there.